Spanish Real World Data on Patients Treated With Durvalumab After Chemoradiotherapy.

NCT04285866 · clinicaltrials.gov ↗

COMPLETED

Status

245

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer (SCLC)

Interventions

DRUG: Durvalumab

Sponsor

Fundación GECP